Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-01-08 @ 1:04 AM
Study NCT ID:
NCT04710134
Status:
COMPLETED
Last Update Posted:
2024-01-25
First Post:
2021-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma
Sponsor:
McMaster University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RES-2020-20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |